Hospital
Hca Health Services of Tennessee, INC.
Hca Health Services of Tennessee, INC. was paid $5.45M by Medicaid between Jan 2018 and Dec 2024, across 35 billing codes. Its largest line is 99283, emergency room visit (moderate) — 66% of everything it billed.
33Billing provider infoHCA HEALTH SERVICES OF TENNESSEE, INC.
ASHLAND CITY, TN 37015
ASHLAND CITY, TN 37015
33aNPI1265487193assigned 05/22/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$5.45M
24GClaims56,729
24DCodes billed35
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Tennessee
Rank by total paid#39 of 71
Median peer was paid$6.96M
This provider vs. median0.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,049 | $839K | |
| 2019 | 8,009 | $726K | |
| 2020 | 6,556 | $582K | |
| 2021 | 9,479 | $811K | |
| 2022 | 10,623 | $971K | |
| 2023 | 6,610 | $708K | |
| 2024incomplete | 6,403 | $811K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 66% | 16,631 | 14,857 | $3.58M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 24% | 5,817 | 4,784 | $1.31M |
| 80053 | Comprehensive metabolic panel | 2.4% | 6,229 | 4,932 | $129K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.4% | 654 | 629 | $75K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1.0% | 356 | 261 | $57K |
| 85027 | <1% | 7,245 | 5,710 | $48K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,626 | 2,079 | $38K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,539 | 1,333 | $36K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,150 | 2,610 | $24K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,014 | 1,511 | $24K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,248 | 1,167 | $22K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,219 | 968 | $20K |
23 more codes
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 319 | $20K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 269 | $8K |
| 83690 | <1% | 1,028 | $7K | |
| 81025 | <1% | 459 | $6K | |
| 81003 | <1% | 854 | $6K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 93 | $6K |
| 87430 | <1% | 228 | $5K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,762 | $5K |
| 81001 | <1% | 582 | $4K | |
| 84484 | <1% | 383 | $3K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 272 | $3K |
| 87070 | <1% | 109 | $2K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 13 | $2K |
| 85378 | <1% | 73 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 474 | $1K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 242 | $1K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 357 | $1K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 146 | $488.86 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 28 | $279.65 |
| 85730 | <1% | 98 | $247.21 | |
| 85610 | <1% | 136 | $238.89 | |
| 87807 | <1% | 13 | $154.66 | |
| G1003 | Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program | 0% | 63 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSUMMERS, DAVID (CFO)
| Provider | Location | Paid |
|---|---|---|
| Frederick Cardiovascular Care PC | Frederick, MD | $1K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.